全文获取类型
收费全文 | 205470篇 |
免费 | 68688篇 |
国内免费 | 1259篇 |
专业分类
耳鼻咽喉 | 3699篇 |
儿科学 | 7766篇 |
妇产科学 | 3701篇 |
基础医学 | 23618篇 |
口腔科学 | 10188篇 |
临床医学 | 40520篇 |
内科学 | 53474篇 |
皮肤病学 | 11034篇 |
神经病学 | 27236篇 |
特种医学 | 6472篇 |
外国民族医学 | 5篇 |
外科学 | 35395篇 |
综合类 | 539篇 |
现状与发展 | 40篇 |
一般理论 | 55篇 |
预防医学 | 20519篇 |
眼科学 | 3672篇 |
药学 | 9199篇 |
中国医学 | 1079篇 |
肿瘤学 | 17206篇 |
出版年
2024年 | 557篇 |
2023年 | 5276篇 |
2022年 | 1531篇 |
2021年 | 4987篇 |
2020年 | 10865篇 |
2019年 | 13600篇 |
2018年 | 16172篇 |
2017年 | 17528篇 |
2016年 | 18554篇 |
2015年 | 18670篇 |
2014年 | 21527篇 |
2013年 | 24532篇 |
2012年 | 10253篇 |
2011年 | 10155篇 |
2010年 | 16149篇 |
2009年 | 15012篇 |
2008年 | 7916篇 |
2007年 | 6047篇 |
2006年 | 7176篇 |
2005年 | 5514篇 |
2004年 | 4794篇 |
2003年 | 4389篇 |
2002年 | 4377篇 |
2001年 | 2971篇 |
2000年 | 2150篇 |
1999年 | 2362篇 |
1998年 | 2652篇 |
1997年 | 2400篇 |
1996年 | 2346篇 |
1995年 | 2126篇 |
1994年 | 1451篇 |
1993年 | 1244篇 |
1992年 | 986篇 |
1991年 | 888篇 |
1990年 | 744篇 |
1989年 | 711篇 |
1988年 | 701篇 |
1987年 | 569篇 |
1986年 | 542篇 |
1985年 | 475篇 |
1984年 | 454篇 |
1983年 | 466篇 |
1982年 | 459篇 |
1981年 | 430篇 |
1980年 | 306篇 |
1979年 | 181篇 |
1978年 | 251篇 |
1977年 | 248篇 |
1976年 | 207篇 |
1974年 | 166篇 |
排序方式: 共有10000条查询结果,搜索用时 430 毫秒
991.
E.K. Lavu FRCPA M. Nelson M.Sc PhD H.J. Popp AAIMS BA J. Gibson FRCP FRCPA PhD H. Kronenberg DCP FRCP FRCPA FRCPath H. Pearson FAIMS A. Child FRCOG 《The Australian & New Zealand journal of obstetrics & gynaecology》1997,37(2):180-183
Summary: regnant women who attended antenatal clinics at King George V Hospital, the Birth Centre or were referred by obstetricians from February to July. 1996 were screened for the platelet antigen HPA-la by flow cytometry. Forty out of 2300 (1.7%) were found to be negative for this antigen . Of the 28 women followed throughout their pregnancy, none developed antibody to HPA-la. Platelet counts performed on samples from 17 babies born to 17 of these mothers were all normal. This study proves the simplicity and rapidity of flow cytometry for platelet antigen screening. The results were comparable with the Solid Phase Red Cell Adherence (SPRCA) method and with PCR. The lack of a plentiful supply of specific antibody and the rarity of fetomaternai alloimmune thrombocytopenia (FMAIT) argue against the introduction of routine screening for maternal HPA-la status at the present time. 相似文献
992.
Dawn Stacey RN MScN CON Annette M. O'Connor RN PhD † Cathy DeGrasse RN MScN ‡ Shailendra Verma MD FRCP § 《Health expectations》2003,6(1):3-18
Objective To develop and evaluate the effectiveness of a breast cancer prevention decision aid for women aged 50 and older at higher risk of breast cancer. Design Pre‐test–post‐test study using decision aid alone and in combination with counselling. Setting Breast Cancer Risk Assessment Clinic. Participants Twenty‐seven women aged 50–69 with 1.66% or higher 5‐year risk of breast cancer. Intervention Self‐administered breast cancer prevention decision aid. Main outcome measures Acceptability; decisional conflict; knowledge; realistic expectations; choice predisposition; intention to improve life‐style practices; psychological distress; and satisfaction with preparation for consultation. Results The decision aid alone, or in combination with counselling, decreased some dimensions of decisional conflict, increased knowledge (P < 0.01), and created more realistic expectations (P < 0.01). The aid in combination with counselling, significantly reduced decisional conflict (P < 0.01) and psychological distress (P < 0.02), helped the uncertain become certain (P < 0.02), and increased intentions to adopt healthier life‐style practices (P < 0.03). Women rated the aid as acceptable, and both women and practitioners were satisfied with the effect it had on the counselling session. Conclusion The decision aid shows promise as a useful decision support tool. Further research should compare the effect of the decision aid in combination with counselling to counselling alone. 相似文献
993.
Brian F O'Donnell Marcia A Wilt Ann Marie Hake Julie C Stout Sandra C Kirkwood Tatiana Foroud 《Movement disorders》2003,18(9):1027-1034
Disturbances of visual cognition, visuomotor performance, and visual memory have been described frequently in Huntington's disease (HD). Early stage visual abnormalities could contribute to these deficits. We evaluated visual processing in 20 control subjects who were non-gene carriers at risk for HD, nine presymptomatic gene-positive subjects, and eight subjects with a recent diagnosis of Huntington's disease. Visual perceptual tests of contrast sensitivity and motion discrimination were used to probe early stage visual processing. Extraocular movements were evaluated in a neurologic examination, and the Digit Symbol test was used to test visual motor performance. Contrast sensitivity did not differ among the three groups. Motion discrimination was impaired in HD subjects but not in the presymptomatic gene carriers when compared to gene noncarriers. Among gene carriers, impaired motion discrimination performance was associated with poorer Digit Symbol performance and extraocular abnormalities. These findings suggest that the early stages of HD are associated with disturbances of motion perception as well as disruptions of visual motor and ocular motor performance. 相似文献
994.
995.
Rosendo A Rodriguez MD PhD Garry Cornel FRCS Lloyd Semelhago MD William M Splinter MD Nihal A Weerasena FRCS 《The Annals of thoracic surgery》1997,64(6):1820-1822
A pediatric cardiac case of transient obstruction of the superior vena cava by the venous cannula before cardiopulmonary bypass is presented. With venous obstruction and increase in central venous pressure, reduced cerebral blood flow velocities and absence of diastolic Doppler flow were detected. This was followed by regional cerebral venous oxygen desaturation and global electroencephalographic slowing. Reposition of the venous cannula led to the recovery of these physiologic indicators and a noncomplicated clinical outcome. 相似文献
996.
997.
998.
Comparison of p53 expression in proximal and distal gastric cancer: Histopathologic correlation and prognostic significance 总被引:2,自引:0,他引:2
Huihuan Tang MD Shuichi Hokita MD PhD Xiangming Che MD Masamichi Baba MD PhD Kuniaki Aridome MD PhD Fumio Kijima MD Gen Tanabe MD PhD Sonshin Takao MD PhD Dr. Takashi Aikou MD PhD 《Annals of surgical oncology》1997,4(6):470-474
Background: The overexpression of p53 has been found to be correlated with prognosis of some carcinomas, including gastric cancer, but
no studies have reported on its relationship to the location of gastric cancer. In the present study, we compared the p53
expression of proximal and distal gastric cancer concerning histopathology and prognosis.
Methods: A total of 170 tumors in the patients with proximal (80 cases) and distal (90 cases) gastric cancer were studied by immunohistochemical
methods.
Results: p53 immunopositivity was detected in 28.8% of all tumors. The p53-positive expression in proximal gastric cancer was higher
than in distal gastric cancer (38.8% vs. 20.0%, p<0.05). A 5-year survival analysis showed that there is no significant difference
between tumors that are p53 positive and p53 negative. No correlation was found between p53 expression and histopathology
of gastric cancer.
Conclusion: p53 nuclear staining is not useful as a prognostic indicator or as a parameter in gastric cancer. 相似文献
999.
Dr. Seema A. Khan MD Nick J. Gonchoroff DrPH Linda E. Miller PhD 《Annals of surgical oncology》1997,4(6):462-469
Background: Many studies have addressed the effect of the timing of surgery for breast cancer relative to menstrual cycle phase, with
conflicting results. Explanations for the possibility that survival could be altered by the appropriate timing of breast cancer
surgery in humans remain speculative.
Methods: We examined the expression of three estrogen related proteins (c-erbB-2, cathepsin D, pS2) in the breast tumors from 69 premenopausal women sampled in different phases of the menstrual cycle.
Data on S-phase fraction and hormone receptor expression were also analyzed. Immunohistochemical assays were used to measure
the proteins of interest. S-phase fraction was determined by flow cytometry. Analyses were performed based on fraction of
cells staining positive for the protein, density of stain, and a histoscore that combined both fraction of positive cells
and density.
Results: We found no differences in c-erbB-2, cathepsin D, hormone receptor, or S-phase levels in tumors sampled in the follicular versus luteal phase, or perimenstrual
versus periovulatory phase. The exception was pS2, which was expressed at greater levels during the luteal than during the
follicular phase of the cycle (p<0.01); but there was no difference in pS2 expression when the patients were classified as
periovulatory versus perimenstrual.
Conclusions: Our findings do not support a variation in c-erbB-2, cathepsin D, S-phase fraction, or receptor expression as an explanation for the differences in breast cancer prognosis
when surgery is timed by menstrual cycle phase. The finding that pS2 (an indicator of hormone sensitivity, and possibly better
prognosis) is expressed at higher levels in tumor samples during the luteal phase suggests that the biologic profile of breast
tumors may vary with the menstrual cycle and that these variations deserve further study. 相似文献
1000.
Effects of race and socioeconomic status on survival of 1,332 black, hispanic, and white women with breast cancer 总被引:3,自引:0,他引:3
Dr. Luisa Franzini PhD Anna Fay Williams PhD Jack Franklin PhD S. Eva Singletary MD Richard L. Theriault DO 《Annals of surgical oncology》1997,4(2):111-118
Background: A survival disadvantage for black women with brest cancer, which persists after controlling for stage of the disease, has been reported. This study investigates the effects of race and socioeconomic status (SES) on breast cancer survival after controlling for age, stage, histology, and type of treatment.
Methods: Kaplan-Meier and Cox proportional hazards models were used to analyze the interaction between race and SES in predicting survival in a sample of 163 black, 205 Hispanic, and 964 white women with breast cancer treated at M. D. Anderson Cancer Center (1987–1991).
Results: The results of univariate and multivariate analyses indicate that race was not a significant predictor of survival after adjusting for SES and other confounding factors such as demographic and disease characteristics. SES remained a significant predictor of survival after all adjustments were made. There was no evidence of differences in type of treatment by race or SES if adjustments were made for stage.
Conclusions: These results suggest that institutional factors, such as access to treatment, do not explain survival differences by race or SES. Other factors associated with low SES, such as life-style and behavior, may affect survival. 相似文献